Rischin D, Brungs D, Day F, Christie H, Patel V, Adams G, Estes Jackson J, De Liz Vassen Schurmann M, Kirtbaya D, Shin T, Hart C, Stankevich E, Li S, Lowy I, Han H, Gonçalves P, Fury M, Porceddu S. C-POST protocol update: A Phase 3, randomized, double-blind study of adjuvant cemiplimab versus placebo post surgery and radiation therapy in patients with high-risk cutaneous squamous cell carcinoma. J of Skin [Internet]. 2023Mar.13 [cited 2024Oct.26];7(2):s173. Available from: https://skin.dermsquared.com/skin/article/view/1996